US FDA approves Nuvation Bio's rare lung cancer drug
Published on 06/11/2025 at 13:34, updated on 06/11/2025 at 14:44
Share
Share

Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.305 USD | -2.74% |
|
+10.77% | -12.97% |
Jun. 30 | Nuvation Bio Inc.(NYSE:NUVB) added to Russell 3000 Growth Index | CI |
Jun. 30 | Nuvation Bio Inc.(NYSE:NUVB) added to Russell Small Cap Comp Growth Index | CI |
Published on 06/11/2025 at 13:34, updated on 06/11/2025 at 14:44
Select your edition
All financial news and data tailored to specific country editions